ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea flag South Korea · Delayed Price · Currency is KRW
146,700
-4,100 (-2.72%)
At close: Feb 6, 2026

ST Pharm Revenue

ST Pharm had revenue of 81.91B KRW in the quarter ending September 30, 2025, with 32.75% growth. This brings the company's revenue in the last twelve months to 318.32B, up 14.24% year-over-year. In the year 2024, ST Pharm had annual revenue of 273.75B, down -3.94%.

Revenue (ttm)
318.32B
Revenue Growth
+14.24%
P/S Ratio
9.54
Revenue / Employee
485.98M
Employees
655
Market Cap
3.04T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024273.75B-11.24B-3.94%
Dec 31, 2023284.99B35.67B14.31%
Dec 31, 2022249.32B83.68B50.52%
Dec 31, 2021165.64B41.53B33.47%
Dec 31, 2020124.11B30.85B33.08%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4.56T
Celltrion3.90T
Hanmi Science1.34T
PharmaResearch496.03B
Hugel404.19B
Celltrion Pharm274.73B
Sam Chun Dang Pharm.220.74B
ALTEOGEN202.18B
Revenue Rankings